Standout Papers

The size and burden of mental disorders and other disorders of the brain in Euro... 2008 2026 2014 2020 2.5k
  1. The size and burden of mental disorders and other disorders of the brain in Europe 2010 (2011)
    Hans‐Ulrich Wïttchen, Frank Jacobi et al. European Neuropsychopharmacology
  2. Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies (2012)
    Filippo Varese, Feikje Smeets et al. Schizophrenia Bulletin
  3. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–persistence–impairment model of psychotic disorder (2008)
    Jim van Os, Richard J. Linscott et al. Psychological Medicine
  4. Schizophrenia (2009)
    Jim van Os, Shitij Kapur The Lancet
  5. The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis (2010)
    Anne‐Kathrin Fett, Wolfgang Viechtbauer et al. Neuroscience & Biobehavioral Reviews
  6. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications (2005)
    John Read, Jim van Os et al. Acta Psychiatrica Scandinavica
  7. The environment and schizophrenia (2010)
    Jim van Os, Günter Kenis et al. Nature
  8. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders (2012)
    Richard J. Linscott, Jim van Os Psychological Medicine
  9. Schizophrenia (2015)
    René S. Kahn, Iris E. Sommer et al. Nature Reviews Disease Primers
  10. Evidence that three dimensions of psychosis have a distribution in the general population (2002)
    Nicholas C. Stefanis, M. Hanssen et al. Psychological Medicine
  11. Strauss (1969) revisited: a psychosis continuum in the general population? (2000)
    Jim van Os, Manon Hanssen et al. Schizophrenia Research
  12. THE CONTINUITY OF PSYCHOTIC EXPERIENCES IN THE GENERAL POPULATION (2001)
    Louise Johns, Jim van Os Clinical Psychology Review
  13. Cannabis Use and Psychosis: A Longitudinal Population-based Study (2002)
    Jim van Os American Journal of Epidemiology
  14. Experience sampling research in psychopathology: opening the black box of daily life (2009)
    Inez Myin‐Germeys, Margreet Oorschot et al. Psychological Medicine
  15. Childhood abuse as a risk factor for psychotic experiences (2003)
    I. Janssen, Lydia Krabbendam et al. Acta Psychiatrica Scandinavica
  16. Stress-reactivity in psychosis: Evidence for an affective pathway to psychosis (2007)
    Inez Myin‐Germeys, Jim van Os Clinical Psychology Review
  17. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people (2004)
    Cécile Henquet, Lydia Krabbendam et al. BMJ
  18. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives (2007)
    Baer Arts, Nienke Jabben et al. Psychological Medicine
  19. Definition and description of schizophrenia in the DSM-5 (2013)
    Rajiv Tandon, Wolfgang Gäebel et al. Schizophrenia Research
  20. Evidence That Onset of Clinical Psychosis Is an Outcome of Progressively More Persistent Subclinical Psychotic Experiences: An 8-Year Cohort Study (2009)
    Maria-de-Gracia Dominguez, Marieke Wichers et al. Schizophrenia Bulletin
  21. Psychosis as a transdiagnostic and extended phenotype in the general population (2016)
    Jim van Os, Ulrich Reininghaus World Psychiatry
  22. Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis (2014)
    Maarten Bak, Annemarie Fransen et al. PLoS ONE
  23. The clinical characterization of the patient with primary psychosis aimed at personalization of management (2021)
    Mario Maj, Jim van Os et al. World Psychiatry

Immediate Impact

3 by Nobel laureates 7 from Science/Nature 108 standout
Sub-graph 1 of 19

Citing Papers

The sleep–circadian interface: A window into mental disorders
2024 Standout
Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial
2023 Standout
24 intermediate papers

Works of Jim van Os being referenced

The size and burden of mental disorders and other disorders of the brain in Europe 2010
2011 Standout
Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients
2003
and 14 more

Author Peers

Author Last Decade Papers Cites
Jim van Os 35669 22959 14918 1.1k 66.8k
Patrick D. McGorry 36324 21093 7185 980 58.1k
Robin Murray 41055 18584 6941 1.5k 87.3k
Peter B. Jones 21701 15301 4898 839 48.1k
Kenneth S. Kendler 12462 26620 15490 1.2k 65.3k
Anthony S. David 25980 12308 10173 959 54.6k
Philip McGuire 24708 8996 8644 856 54.5k
John M. Kane 35238 9441 3695 913 51.0k
Ming T. Tsuang 22870 12883 5664 831 47.8k
Nancy C. Andreasen 28611 10011 7008 502 55.7k
David J. Kupfer 20400 14514 18841 732 59.5k

All Works

Loading papers...

Rankless by CCL
2026